Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021
Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021
Thu, March 18, 2021
Wed, March 17, 2021

Andrew Fein Maintained (BCRX) at Strong Buy with Increased Target to $19 on, Mar 24th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-19-on-mar-24th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy with Increased Target from $14 to $19 on, Mar 24th, 2021.

Andrew has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $9 on, Friday, January 22nd, 2021


This is the rating of the analyst that currently disagrees with Andrew


  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $12 on, Tuesday, November 24th, 2020

Publication Contributing Sources